Patent ID: 11896671
Assignee: ASCENDIS PHARMA A/S
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A

Claim 15:
16. The compound of claim 15, wherein —Ra1 of formula (IV) is selected from the group consisting of methyl, ethyl, propyl,, wherein
—Rc1 and —Rc1a are independently of each other selected from the group consisting of —H, -T0 and C1-6 alkyl;
—Rd is selected from the group consisting of C1-6 alkyl and —NO2, —CN, —C(O)ORe, —S(O)2ORe;
each -T0 is independently of each other selected from the group consisting of phenyl, naphthyl, indenyl, indanyl, tetralinyl, C3-10 cycloalkyl, 3- to 10-membered heterocyclyl, and 8- to 11-membered heterobicyclyl; wherein each -T0 is independently optionally substituted with one or more —Re, which are the same or different;
each —Re is independently C1-6 alkyl;
n is selected from the group consisting of 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10;
m is selected from the group consisting of 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10; and
p is selected from the group consisting of 0, 1, 2, 3, 4 and 5.